Skip to content

Early Origins of Allergy and Asthma

Early Origins of Allergy and Asthma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04186949
Acronym
ARIES
Enrollment
273
Registered
2019-12-05
Start date
2018-10-09
Completion date
2022-12-31
Last updated
2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Sensitisation, Allergy, Asthma, Atopic Dermatitis, Food Allergy

Keywords

birth cohort, Chile

Brief summary

Birth cohort study with recruitment during pregnancy to determine prenatal and perinatal conditions, as well as genetic and epigenetic factors, that participate in the early setting of immune responses, and the role of these in the later determination of the risk of allergic diseases, asthma, and metabolic conditions in the offspring.

Detailed description

Despite recent advances in the understanding of the pathogenesis of allergies and asthma, these diseases still have no clear preventative measures or curative treatments. Growing evidence shows that atopic dermatitis (AD), food allergy (FA), allergic rhinitis, and asthma are largely determined during the first 1000 days (time elapsed from conception to the 2nd birthday). This cohort aims to determine prenatal and perinatal conditions, as well as genetic and epigenetic factors, that participate in the early setting of immune responses, and the role of these in the later determination of the risk of allergic diseases, and asthma in the offspring. The investigators have designed a birth cohort of 250 families with recruitment in pregnancy (\ 14 weeks). The plan is to genotype relevant allergy/asthma-associated variants and will perform immunophenotyping and evaluation of allergy biomarkers in cord blood. At 2 years of age the investigators will assess if infants have developed allergic sensitization, AD, FA, as well as biomarkers of asthma including the asthma predictive index. The study will also evaluate how maternal conditions modify immune programming through epigenetic modifications, and will then confirm newborn epigenetic cues of allergy/asthma risk. Next, the investigators will assess composition/diversity of maternal gut, placenta, breastmilk and infant gut microbiome and their association with immunophenotype and biomarkers at birth, and clinical outcomes at age 2. Finally, another specific objective is to assess how environmental exposures (perinatal outdoor and indoor pollution, endotoxin and allergens) affect the incidence of allergic sensitization, AD, FA, and risk of asthma.

Interventions

None listed

Sponsors

University of Chile
CollaboratorOTHER
Comisión Nacional de Investigación Científica y Tecnológica
CollaboratorOTHER_GOV
Pontificia Universidad Catolica de Chile
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women living in Chile's central regions * Offspring of women recruited in the cohort study

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Development of allergic diseases in offspring2 yearsAtopic dermatitis, food allergy, allergic sensitization, predicted increased risk of asthma

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026